Basaglar (Insulin Glargine): Availability, Dosing, Cost & How to Find It in Stock
What Is Basaglar?
Basaglar is a long-acting insulin used to manage blood sugar in adults and children with diabetes. It contains insulin glargine — the same active ingredient found in Lantus — and was approved by the FDA in December 2015 as the first biosimilar insulin in the United States. While it's not a generic in the traditional small-molecule sense, Basaglar is considered a biosimilar: a highly similar version of a reference biologic drug (Lantus) that has been shown to have no clinically meaningful differences in safety or effectiveness. It's manufactured by Eli Lilly in partnership with Boehringer Ingelheim.
Basaglar is FDA-approved for improving glycemic control in adults with type 2 diabetes and in adults and pediatric patients (age 6 and older) with type 1 diabetes. It's prescribed as a once-daily injection and works as a basal insulin — meaning it provides a steady, background level of insulin coverage throughout the day and night, rather than covering meals. It's typically prescribed by endocrinologists, primary care physicians, and internists, though any licensed prescriber can write for it. Patients who take Basaglar often pair it with a short-acting or rapid-acting insulin to cover mealtime blood sugar spikes.
As a biosimilar rather than a small-molecule generic, Basaglar is sold under its brand name and is not automatically substituted at the pharmacy the way traditional generics are. Your pharmacist will dispense exactly what's written on your prescription unless your doctor authorizes a substitution — and in most states, biosimilar substitution rules are still evolving. Basaglar comes in a prefilled KwikPen device and in vials compatible with standard insulin syringes. If you're having trouble finding Basaglar, FindUrMeds can locate it at a pharmacy near you.
How Does Basaglar Work?
Basaglar works by mimicking the role that naturally produced insulin plays in your body. In people with diabetes, the pancreas either doesn't produce insulin (type 1) or doesn't produce enough — or the body doesn't use it effectively (type 2). Without insulin, glucose can't enter your cells and instead builds up in your bloodstream. Basaglar's active ingredient, insulin glargine, binds to insulin receptors throughout the body, signaling cells to absorb glucose from the blood and use it for energy. It also suppresses the liver's tendency to release stored glucose when it isn't needed, which is a major driver of high fasting blood sugar.
What makes insulin glargine distinct from other insulins is its pharmacokinetic profile — essentially, how it behaves over time once injected. After a subcutaneous injection (typically into the abdomen, thigh, or upper arm), Basaglar has an onset of approximately 1–2 hours. It reaches a relatively flat, stable activity level with no pronounced peak — unlike NPH insulin, which spikes sharply. Its duration of action is approximately 24 hours, which is why it's dosed once daily. That peakless, steady profile is what makes it a basal insulin: it doesn't cause sudden drops in blood sugar the way a meal-coverage insulin does, but instead maintains a consistent baseline that keeps fasting and between-meal glucose levels in check.
Available Doses of Basaglar
Basaglar is available in the following FDA-approved formulations and concentrations:
- Basaglar KwikPen — 100 units/mL (U-100), prefilled 3 mL pen (300 units total), sold in boxes of 5 pens
- Basaglar Tempo Pen — 100 units/mL (U-100), prefilled 3 mL pen with connected device compatibility, sold in boxes of 5 pens
- Basaglar Vial — 100 units/mL (U-100), 10 mL vial (1,000 units total), for use with standard U-100 insulin syringes
Basaglar is only available in the U-100 concentration. It is not available in the higher-concentration U-300 format (that's Toujeo, a different product). The dose you inject is individualized — there is no single universal starting dose — but typical starting doses for adults with type 2 diabetes are often 10 units once daily, adjusted over time based on fasting glucose readings, with your doctor's guidance. Children with type 1 diabetes typically start at doses calculated per kilogram of body weight.
- The KwikPen is the most commonly dispensed form and is what most insurance formularies cover
- The Tempo Pen includes Bluetooth connectivity for tracking injection data via a compatible app — useful for some patients but not universally available at all pharmacies
- The vial is often preferred by patients who require very small or very large doses, or who use insulin pumps (though Basaglar is not officially approved for pump use — consult your doctor)
Having trouble finding a specific dose? FindUrMeds searches all strengths simultaneously.
Basaglar Findability Score
Basaglar Findability Score: 62 / 100
Our Findability Score is a proprietary 1–100 metric that reflects how readily available a medication is across our national pharmacy network of 15,000+ locations. A score of 100 means you can walk into virtually any pharmacy and find it on the shelf. A score of 1 means it's exceptionally difficult to source — think controlled substances under strict DEA quota, or drugs on active FDA shortage. Basaglar's score of 62 out of 100 places it in the moderate availability tier: findable, but not reliably available at any given pharmacy on any given day.
Several factors shape Basaglar's score. Unlike controlled substances, insulin glargine is not subject to DEA Schedule quotas. It's also not currently listed on the FDA Drug Shortage Database as of this writing, and Eli Lilly has not issued any public supply disruption notices for Basaglar. So why isn't the score higher? The primary driver is formulary and stocking behavior at the retail level. Because Basaglar competes directly with Lantus (the reference product), Tresiba, and Toujeo — all of which hold strong formulary positions at major pharmacy chains — many pharmacies choose to stock only one or two long-acting insulins rather than all of them. A CVS location in one ZIP code may carry Lantus and Toujeo but not Basaglar, while a Walgreens two miles away stocks Basaglar and Tresiba but not Lantus. Stocking decisions vary by chain, by region, and sometimes by individual store.
For patients, this means that a prescription for Basaglar isn't a guarantee that your nearest pharmacy has it. According to our data across 40,000+ pharmacy searches involving long-acting insulins, patients who search without assistance contact an average of 7–12 pharmacies before finding their specific insulin in stock. For Basaglar specifically, our platform's analysis found that approximately 1 in 3 patients encounter an out-of-stock situation on their first call. The Pharmacy Call Index for Basaglar — a measure of average number of calls required before a patient confirms stock — sits at 4.2, compared to a platform average of 2.8 across all medications.
The good news: our success rate for locating Basaglar is 91%, close to our platform-wide rate of 92%. Most patients who use FindUrMeds find their Basaglar within 24–48 hours. Skip the pharmacy calls. FindUrMeds finds Basaglar for you.
Basaglar Pricing
Insulin pricing in the United States is genuinely complex — it varies by insurance tier, pharmacy chain, region, and whether you're using a copay card or patient assistance program. Here's a realistic breakdown to set your expectations:
With Insurance: Basaglar's cost to you depends heavily on your plan's formulary. Many commercial insurance plans place Basaglar on Tier 2 or Tier 3, with typical copays ranging from $25–$60 per box of 5 KwikPens (a roughly 30-day supply for most patients). Some high-deductible plans may require you to pay more until your deductible is met.
Without Insurance (Cash Price): The list price of Basaglar KwikPens (box of 5, 3 mL each) is approximately $170–$230 depending on the pharmacy. The 10 mL vial runs approximately $140–$190 at retail. These are list prices — before any discount programs.
GoodRx and Discount Platforms: GoodRx pricing for Basaglar KwikPen (5 pens, 100 units/mL) typically ranges from $85–$150 depending on the pharmacy and location. Using a GoodRx coupon at a Walmart or Costco pharmacy tends to yield the lowest prices in most regions.
Eli Lilly's Patient Assistance Programs: Eli Lilly offers several programs worth knowing about:
- Lilly Insulin Value Program: Caps out-of-pocket costs at $35/month for eligible patients, regardless of insurance status. This applies to Basaglar. Available at participating pharmacies.
- Lilly Cares Foundation: For uninsured or underinsured patients who meet income requirements, Basaglar may be available at no cost or very low cost through this patient assistance program. Visit the Lilly Cares website or ask your doctor's office to assist with enrollment.
- Manufacturer Copay Card: Commercially insured patients (not those on Medicare, Medicaid, or other government plans) may be eligible for a copay card that further reduces out-of-pocket costs.
Price varies by pharmacy, region, and plan. Always call your pharmacy with your insurance information before assuming a price. A pharmacist can often tell you your exact copay in under two minutes.
Who Can Prescribe Basaglar?
Basaglar is a prescription medication and requires a valid prescription from a licensed prescriber. The following healthcare providers are authorized to prescribe it:
- Endocrinologists — Specialists in diabetes and hormonal disorders; the most common prescribers for complex type 1 and type 2 cases
- Primary Care Physicians (MDs, DOs) — The most common prescribers for type 2 diabetes in routine care
- Internal Medicine Physicians — Often manage adult diabetes alongside other chronic conditions
- Nurse Practitioners (NPs) — Can prescribe independently in most US states; commonly prescribe insulin in both primary care and specialty settings
- Physician Assistants (PAs) — Can prescribe in all 50 states, typically under physician oversight
- Certified Diabetes Care and Education Specialists (CDCES) — Can often prescribe under collaborative practice agreements, depending on state law
- OB-GYNs and Maternal-Fetal Medicine Specialists — May prescribe insulin glargine for gestational diabetes in appropriate clinical situations
- Telemedicine Providers — Following the end of the federal COVID-19 public health emergency, telemedicine prescribing rules have reverted in part to state law. Most states allow telemedicine providers to prescribe non-controlled medications like Basaglar after a valid patient-provider relationship is established, which may or may not require an initial in-person visit depending on your state. Platforms like Teladoc, MDLive, and diabetes-specific telehealth services commonly prescribe insulin glargine.
Once you have your prescription, the harder problem is finding a pharmacy that has it. That's where FindUrMeds comes in.
Basaglar Side Effects
Understanding what to expect from Basaglar helps you use it safely and confidently. Like all insulins, most of its side effects are predictable and manageable.
Most Common Side Effects
- Hypoglycemia (low blood sugar) — The most common side effect of any insulin. Symptoms include shakiness, sweating, confusion, rapid heartbeat, and hunger. Usually mild and correctable with fast-acting sugar (glucose tablets, juice, regular soda). Occurs in virtually all patients at some point; frequency depends heavily on dose and diet.
- Injection site reactions — Redness, itching, swelling, or mild pain at the injection site. Most common when you're new to injecting; typically diminishes over weeks.
- Lipohypertrophy — Lumpy or thickened skin from injecting in the same spot repeatedly. Rotate your injection sites to prevent this.
- Weight gain — Insulin promotes glucose storage, which can contribute to modest weight gain, especially early in treatment. Typically 1–4 lbs over the first several months; varies by patient.
- Edema (fluid retention) — Mild swelling, particularly in the feet and ankles, can occur when blood sugar control improves rapidly. Usually temporary.
Less Common but Serious Side Effects
- Severe hypoglycemia — Loss of consciousness, seizure, or inability to self-treat. Requires glucagon injection or emergency assistance. Contact your provider immediately after any severe hypoglycemic episode, and talk to them about adjusting your dose.
- Hypokalemia (low potassium) — Insulin drives potassium into cells along with glucose, which can lower blood potassium levels. Can be serious in patients with certain heart or kidney conditions. Contact your provider if you experience muscle cramps, weakness, or irregular heartbeat.
- Serious allergic reactions — Rare but possible. Signs include rash spreading beyond the injection site, trouble breathing, rapid heartbeat, or swelling of the face/throat. Seek emergency care immediately.
- Vision changes — Rapid improvement in blood sugar control can temporarily cause blurry vision due to changes in fluid in the lens of the eye. Contact your provider if this persists beyond a few weeks.
- Heart failure worsening — In patients with pre-existing heart failure, insulin can worsen fluid retention. Contact your provider if you notice sudden weight gain, increased swelling, or shortness of breath.
Side Effects That Typically Improve Over Time
If you're new to Basaglar, injection site discomfort and mild swelling often resolve within the first 2–4 weeks as your body adjusts. The mild fatigue some patients notice during the initial period of blood sugar normalization usually resolves as your glucose levels stabilize.
This information is for educational purposes only and does not replace individualized medical advice. Talk to your doctor or pharmacist about any side effects you're experiencing. Do not adjust your insulin dose without guidance from your healthcare provider.
Alternatives to Basaglar
Basaglar isn't the only option for long-acting insulin coverage. If availability is an issue — or if your insurance formulary or clinical situation calls for it — there are several well-established alternatives your doctor may consider.
Same-Class Alternatives (Long-Acting Insulins)
- Lantus (insulin glargine, Sanofi) — The original reference product; same active ingredient as Basaglar. Often stocked where Basaglar isn't, and vice versa. Interchangeable for most patients with prescriber authorization.
- Toujeo (insulin glargine U-300, Sanofi) — A higher-concentration form of insulin glargine (300 units/mL vs. 100 units/mL). Slightly longer and flatter action profile; useful for patients who need larger doses or experience dawn phenomenon.
- Semglee (insulin glargine-yfgn) — An FDA-designated interchangeable biosimilar insulin glargine from Biocon/Viatris. Legally interchangeable with Lantus, meaning a pharmacist can substitute it without calling the prescriber (varies by state). Often priced competitively.
- Rezvoglar (insulin glargine-aglr) — Another interchangeable biosimilar insulin glargine, also from Eli Lilly. Functionally similar to Basaglar with interchangeable designation.
- Tresiba (insulin degludec, Novo Nordisk) — An ultra-long-acting insulin with a duration of up to 42 hours. More flexible dosing window; may offer more consistent overnight control for some patients.
- Levemir (insulin detemir, Novo Nordisk) — Another long-acting option; slightly shorter duration than glargine-based insulins (up to 24 hours), sometimes dosed twice daily. Being phased out in the US — availability may be limited.
- NPH Insulin (Humulin N / Novolin N) — An older intermediate-acting insulin. Available over the counter without a prescription in many states. Less consistent profile than glargine-based insulins, but significantly less expensive.
Different-Mechanism Alternatives
For patients with type 2 diabetes who aren't achieving control with basal insulin alone — or who may not yet need insulin — there are non-insulin options your doctor might consider:
- GLP-1 Receptor Agonists (semaglutide/Ozempic, Trulicity/dulaglutide, Victoza/liraglutide) — Injectable medications that stimulate insulin release and suppress glucagon; some offer significant weight loss benefits. Often considered before initiating basal insulin in type 2 diabetes.
- SGLT-2 Inhibitors (empagliflozin/Jardiance, dapagliflozin/Farxiga, canagliflozin/Invokana) — Oral medications that lower blood sugar by increasing glucose excretion in the urine. Added cardiovascular and kidney-protective benefits in appropriate patients.
- Combination GLP-1 + Basal Insulin (Xultophy/insulin degludec + liraglutide; Soliqua/insulin glargine + lixisenatide) — Combination products that combine a basal insulin with a GLP-1 agonist in a single daily injection.
These alternatives require a conversation with your prescriber — not all are appropriate for every patient or diabetes type.
If you'd prefer to stick with Basaglar, FindUrMeds has a high success rate finding it in stock.
Drug Interactions with Basaglar
Insulin glargine has a range of clinically relevant drug interactions. This list is not exhaustive — always review your full medication list with your doctor or pharmacist.
Serious Interactions
- Other insulins — Mixing Basaglar with other insulins in the same syringe is not recommended. Unlike some insulins (e.g., regular insulin and NPH), insulin glargine cannot be mixed due to its acidic pH, which can alter the pharmacokinetics of both insulins.
- Thiazolidinediones (pioglitazone, rosiglitazone) — Combination with insulin significantly increases the risk of heart failure and fluid retention. If used together, your doctor should monitor closely for signs of edema or weight gain.
- ACE inhibitors and ARBs (lisinopril, losartan, etc.) — Can enhance insulin's blood-sugar-lowering effect, increasing hypoglycemia risk. Not a contraindication, but your dosing may need adjustment.
- Antidiabetic agents — Other blood sugar-lowering medications (metformin, sulfonylureas like glipizide, SGLT-2 inhibitors, GLP-1 agonists) combined with insulin increase hypoglycemia risk, particularly sulfonylureas. Doses may need careful coordination.
- Beta-blockers (metoprolol, atenolol, carvedilol) — Can mask the warning signs of hypoglycemia (especially rapid heartbeat) and may also prolong or worsen hypoglycemic episodes. Non-selective beta-blockers carry more risk than selective ones.
Moderate Interactions
- Corticosteroids (prednisone, dexamethasone) — Steroids raise blood sugar significantly and can dramatically reduce insulin's effectiveness. Patients on short courses of steroids often require temporary dose increases.
- Fluoroquinolone antibiotics (ciprofloxacin, levofloxacin) — Can cause unpredictable changes in blood sugar — both hypoglycemia and hyperglycemia have been reported. Monitor blood sugar closely during a course.
- Antipsychotics (olanzapine, quetiapine, clozapine) — Atypical antipsychotics can cause insulin resistance and elevated blood sugar, potentially requiring insulin dose adjustment.
- Thyroid hormones (levothyroxine) — Changes in thyroid status can alter insulin requirements. If your thyroid dose changes, monitor blood sugar more closely.
- Diuretics (furosemide, hydrochlorothiazide) — Thiazide and loop diuretics can raise blood sugar and may reduce insulin effectiveness.
- Niacin (high-dose) — Can increase blood sugar and may require insulin dose adjustment.
Food and Substance Interactions
- Alcohol — A significant interaction. Alcohol inhibits the liver's ability to release stored glucose, which can cause prolonged or severe hypoglycemia, especially if you drink without eating. The risk is greatest 4–12 hours after drinking. Moderate alcohol consumption with food is generally manageable, but heavy drinking is dangerous in insulin-dependent patients.
- High-fat, high-carbohydrate meals — Don't directly interact with Basaglar pharmacokinetically, but erratic eating patterns make blood sugar management unpredictable. Consistency in meal timing and composition helps Basaglar work as intended.
- Caffeine — High caffeine intake can transiently raise blood sugar in some people with diabetes, though the effect is modest and varies significantly by individual.
- Cannabis — Can increase appetite and affect blood sugar unpredictably; may mask hypoglycemia symptoms in some users.
How to Find Basaglar in Stock
This is where the rubber meets the road. Having a valid prescription is step one — but if your pharmacy is out of stock, that prescription is just a piece of paper. Here's a practical, step-by-step approach to finding Basaglar near you.
1. Use FindUrMeds — The Fastest Route
FindUrMeds was built specifically for this problem. Here's how it works:
- You submit your medication details — drug name, dose, quantity, and your ZIP code — through our online form. It takes under 2 minutes.
- Our team contacts pharmacies on your behalf — We reach out across our network of 15,000+ locations, including CVS, Walgreens, Rite Aid, Walmart, Kroger, Publix, Costco, and Sam's Club, checking real-time inventory so you don't have to.
- You hear back within 24–48 hours — We confirm which nearby pharmacies have Basaglar in stock, what it costs, and exactly what information to bring to pick it up.
Our success rate for Basaglar specifically is 91%. Patients using FindUrMeds report locating their insulin in an average of 1.3 days, compared to 4–7 days of independent searching. We're trusted by 200+ healthcare providers who refer patients to us directly when pharmacy shortages come up.
2. Use GoodRx to Signal Stock
Here's a trick most patients don't know: when GoodRx displays a price for a specific drug at a specific pharmacy, it's usually a strong indicator that that pharmacy has the drug in stock. GoodRx pulls pricing data from pharmacy systems, and those systems are connected to real inventory.
How to use this:
- Go to GoodRx.com and search "Basaglar KwikPen"
- Enter your ZIP code and scan the pharmacy list
- Pharmacies showing active prices (rather than "unavailable" or blank) are likely to have stock
- Click to get the coupon, then call that specific pharmacy to confirm before driving over
This won't tell you exact unit counts, but it's a fast, free pre-screen that can save you multiple wasted trips.
3. Use Pharmacy Apps (CVS, Walgreens, Walmart)
Major pharmacy chains have mobile apps and websites that sometimes allow you to check prescription drug availability, though this feature varies in reliability:
- CVS Pharmacy App: Search the prescription section for "insulin glargine." If the app allows you to add it to your cart or shows pricing, that's a positive inventory signal. CVS also has a "Ready in an hour" feature for some medications — if Basaglar shows up there, it's stocked.
- Walgreens App: Walgreens' app allows prescription transfers and shows medication availability in some cases. Try searching the pharmacy locator feature and filtering by specialty medication availability.
- Walmart Pharmacy: Walmart tends to carry Basaglar more consistently than some other chains and often has competitive cash pricing. The Walmart Pharmacy website allows you to check if a specific medication is carried at a specific store — use the "Transfer a Prescription" tool and enter the drug name to get a location-level confirmation.
- Costco Pharmacy: Frequently underutilized by patients who don't realize you don't need a Costco membership to use its pharmacy. Costco often stocks long-acting insulins at below-market prices. Call your local Costco pharmacy directly.
4. Call with the Generic Name — Use This Script
When you call a pharmacy, using the brand name "Basaglar" can sometimes result in a quick "no" from a pharmacy technician who may not immediately check all their inventory or who may be looking only at a specific product code. Using the generic name and asking broadly gets better results.
Use this exact script:
"Hi, I'm looking for insulin glargine — do you carry it in stock in any strength? I specifically need the U-100 concentration, either in a KwikPen or vial. The brand name is Basaglar, but I want to make sure you're checking all insulin glargine products."
If they say they only have Lantus or Semglee, ask whether those are covered under your plan or if your doctor can authorize a substitution. In many cases, they can.
Ready to stop calling pharmacies?
Need help finding Basaglar in stock? FindUrMeds contacts pharmacies for you and finds your prescription nearby — usually within 24–48 hours. No more calling around.
Frequently Asked Questions
Is Basaglar still in shortage?
As of this writing, Basaglar is not listed on the FDA Drug Shortage Database, and Eli Lilly has not issued a formal supply disruption notice. However, "shortage" and "out of stock at your local pharmacy" are two different things. Basaglar has a Findability Score of 62/100, which means that while nationwide supply is generally intact, localized stocking gaps at individual pharmacy locations are common. Approximately 1 in 3 patients report hitting an out-of-stock situation on their first attempt to fill Basaglar. If you're struggling to find it, that's not unusual — and it's exactly the problem FindUrMeds solves.
How much does Basaglar cost without insurance?
Without insurance, Basaglar's retail list price is approximately $170–$230 for a box of 5 KwikPens (a roughly 30-day supply for many patients). However, you have options that can dramatically reduce this cost. Eli Lilly's Insulin Value Program caps out-of-pocket costs at $35/month for eligible patients — including those without insurance — at participating pharmacies. GoodRx coupons typically bring the cash price down to $85–$150 depending on your location and pharmacy. The Lilly Cares Foundation offers free or reduced-cost insulin to patients who meet income criteria. If you're uninsured and paying cash for Basaglar, explore these programs before paying full retail price.
Can I get Basaglar through mail order?
Yes. Basaglar can be dispensed through mail-order pharmacies, and this is an option worth exploring — especially if local availability is inconsistent. Most major pharmacy benefit managers (PBMs) offer 90-day supplies through mail order, which often comes with cost savings (many plans charge 2 copays instead of 3 for a 90-day mail supply). Mail-order insulin requires proper cold-chain shipping — your pharmacy will ship it with an ice pack. Note that during periods of extreme summer heat, some mail-order pharmacies may add additional cold-pack materials or require signature on delivery to prevent temperature excursion. Be sure to track your shipment and have a plan to refrigerate it promptly upon arrival.
What's the difference between Basaglar and Lantus?
Basaglar and Lantus contain the exact same active ingredient: insulin glargine at 100 units/mL. They work identically in your body, have the same onset (approximately 1–2 hours), the same peakless activity profile, and the same duration (approximately 24 hours). The difference is manufacturing and cost. Lantus is the original brand-name product made by Sanofi; Basaglar is a biosimilar made by Eli Lilly that was approved after demonstrating it has no clinically meaningful differences from Lantus. In practice, most patients and clinicians consider them interchangeable for the vast majority of type 1 and type 2 diabetes cases. Basaglar is often priced lower on insurance formularies, which is why many patients are switched to it. If your doctor originally prescribed Lantus and your insurance or pharmacist suggests Basaglar, it's worth a quick conversation with your provider — but the switch is usually routine.
What if my pharmacy is out of Basaglar?
First, don't panic — and don't skip a dose of insulin without talking to your healthcare provider. Running out of basal insulin is a genuine medical concern, so act quickly but methodically. Here's what to do:
- Ask your pharmacist if they can order it — Many pharmacies can request stock from their distributor and have it within 24–48 hours if it's in the regional supply chain.
- Ask whether a biosimilar or interchangeable product is available — Semglee and Rezvoglar are both insulin glargine products. Your doctor may authorize a substitution quickly.
- Contact FindUrMeds — We search 15,000+ pharmacies and typically locate Basaglar within 24–48 hours, with a 91% success rate for this specific drug.
- Call your prescriber — If stock can't be located quickly, your doctor may be able to write a bridge prescription for an available long-acting insulin (like Lantus or Tresiba) while your Basaglar is sourced.
- In an emergency — If you're a type 1 patient running out of basal insulin and can't locate any alternative quickly, contact your prescriber or go to an urgent care or emergency department. Do not simply stop taking insulin.
Need help finding Basaglar in stock? FindUrMeds contacts pharmacies for you and finds your prescription nearby — usually within 24–48 hours. No more calling around.
FindUrMeds is committed to providing accurate, evidence-based medication information to help patients in the United States manage their prescriptions. This content is for informational purposes only and does not constitute medical advice. Always consult your doctor or pharmacist before making any changes to your medication regimen.
About FindUrMeds: We contact pharmacies on your behalf and find your prescription in stock nearby, usually within 24–48 hours across 15,000+ US pharmacies. Learn how it works →